Solid Biosciences Inc. - Common Stock $0.001 par value per share (SLDB)

Historical Holders from Q3 2020 to Q3 2025

Symbol
SLDB on Nasdaq
CUSIP
83422E204
Type / Class
Equity / Common Stock $0.001 par value per share
Shares outstanding
77.8M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
81.3M
Holdings value
$502M
% of all portfolios
0.002%
Grand Portfolio weight change
0%
Number of holders
119
Number of buys
61
Number of sells
-48
Average Value change %
0%
Average buys %
+0%
Average sells %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Solid Biosciences Inc. - Common Stock $0.001 par value per share (SLDB)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
PERCEPTIVE ADVISORS LLC 15.6% $32.2M 11.9M Perceptive Advisors LLC Feb 19, 2025
RA CAPITAL MANAGEMENT, L.P. 9.9% $46.4M 8M RA Capital Management, L.P. Aug 12, 2025
Invus Global Management, LLC 9.6% +2.22% $20M $9.9M 7.42M +97.8% Raymond Debbane Mar 31, 2025
BlackRock, Inc. 6.1% $13.7M 4.71M BlackRock, Inc. Jun 30, 2025
Adage Capital Management, L.P. 5.14% -39.3% $24.7M -$16.8M 4M -40.6% Adage Capital Management, L.P. Sep 30, 2025
Vestal Point Capital, LP 2.3% $4.73M 1.75M Vestal Point Capital, LP Mar 31, 2025

Institutional Holders of Solid Biosciences Inc. - Common Stock $0.001 par value per share (SLDB)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 81.3M $502M -$1.77M $6.17 119
2025 Q2 82.2M $400M +$32.1M $4.87 110
2025 Q1 78.8M $292M +$158M $3.70 121
2024 Q4 36.3M $145M -$2.64M $4.00 85
2024 Q3 35.8M $250M -$25.3M $6.97 93
2024 Q2 37.6M $213M +$13.7M $5.67 78
2024 Q1 35M $466M +$255M $13.32 52
2023 Q4 16.6M $102M +$4.58M $6.14 37
2023 Q3 16.2M $40.7M -$463K $2.52 34
2023 Q2 16.3M $85.6M +$3.11M $5.24 34
2023 Q1 15.8M $74.8M +$2.02M $4.74 35
2022 Q4 15M $80.8M +$79.6M $5.38 31
2020 Q4 0 $0 -$623K 0
2020 Q3 307K $623K +$623K $2.03 1